SYRS

Syros Pharmaceuticals, Inc.
OTC Markets OTCPKUSDEQUITY Healthcare DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET ·

Price

Open
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
904
Market cap
$10.73K
P/E (TTM)
52W range
0.00 – 0.02

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.4%
1M
0.00% -3.7%
3M
-50.00% -53.1%
6M
-50.00% -61.1%
YTD
-71.43% -83.7%
1Y
-95.83% -115.8%
3Y
-100.00% -174.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$10.73K
Enterprise value$1.95M
Revenue (TTM)$386.00K
Gross profit$-88.25M
EBITDA$-110.18M
Net income$-97.81M
EPS (TTM)$-3.07
Free cash flow$-57.94M
Total cash$58.27M
Total debt$60.23M
Book value / share$-0.42
Shares outstanding26.83M
Float26.83M
Short % of float3.81%
Dividend yield
Beta (5Y)1.33

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-0.00
PEG ratio
Price / sales
Price / book
EV / revenue5.06
EV / EBITDA-0.02
Gross margin0.00%
Operating margin-28891.71%
Profit margin0.00%
Return on equity-776.96%
Return on assets-59.88%
Debt / equity
Current ratio2.25
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2023202220212020
Total revenue$9.94M$14.88M$23.49M$15.09M
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$164.57M-$94.65M-$86.56M-$84.04M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Sep 2024 -0.67-0.16 +76.0%
Jun 2024 -0.77-0.59 +22.9%
Mar 2024 -0.94-0.10 +89.3%
Dec 2023 -1.12-2.22 -98.9%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter -0.71 3 $0
Current year $0
Next year -2.61 4 $0

Analyst targets & ownership

Account required
Mean target$8.75
High target$20.00
Low target$4.00
Implied upside2187400.00%
Analyst count4
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.07%
Held by institutions9.62%
Institutions holding4
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
20.12K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Dec 2, 24
SIMONIAN NANCY A
Director
SELL 37.07K $10.02K Direct
Nov 25, 24
SIMONIAN NANCY A
Director
SELL 134.71K $35.74K Direct
Nov 19, 24
QUIRK GERALD E.
Officer
SELL 46.66K $12.91K Direct
Nov 18, 24
ROTH DAVID A M.D.
Officer
SELL 12.10K $2.38K Direct
Nov 18, 24
STEPHENS KRISTIN
Officer
SELL 36.13K $7.95K Direct
Nov 18, 24
CHEE CONLEY
Chief Executive Officer
SELL 134.80K $26.93K Direct
Nov 18, 24
HAAS JASON
Chief Financial Officer
SELL 137.80K $28.98K Direct
Oct 31, 24
SIMONIAN NANCY A
Director
40.13K Direct
Oct 31, 24
ROTH DAVID A M.D.
Officer
18.88K Direct
Oct 31, 24
STEPHENS KRISTIN
Officer
17.00K Direct
Oct 31, 24
CHEE CONLEY
Chief Executive Officer
17.00K Direct
Oct 31, 24
HAAS JASON
Chief Financial Officer
18.88K Direct
Sep 30, 24
QUIRK GERALD E.
Officer
10.00K Direct
Sep 16, 24
YOUNG RICHARD A
Director
2.67K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

8 reporting
NameRelationShares heldLatest
AKKARAJU SRINIVAS
Director 9.33K Conversion of Exercise of derivative security
CHEE CONLEY
Chief Executive Officer 0 Sale
HAAS JASON
Chief Financial Officer 0 Sale
QUIRK GERALD E.
Officer 0 Sale
ROTH DAVID A M.D.
Officer 0 Sale
SIMONIAN NANCY A
Director 4.00K Sale
STEPHENS KRISTIN
Officer 0 Sale
YOUNG RICHARD A
Director 10.67K Conversion of Exercise of derivative security

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.00
+73.91% from price
SMA 20
0.00
-48.72% from price
SMA 50
0.00
-34.21% from price
SMA 100
0.00
+96.56% from price
SMA 200
0.00
-68.33% from price
EMA 12
0.00
+82.29% from price
EMA 26
0.00
+109.43% from price
EMA 50
0.00
+117.58% from price
RSI (14)
47.6
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.00
228.57% of price
Realised vol 30D
1344.4%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
-0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
-68.33%

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.14
Less volatile than market
Correlation to SPY
-0.00
Largely independent
Realised vol 30D
1344.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.5%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
228.57% of price
Beta (reported)
1.33
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 0.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.